Trade Summary

3 days ago, Lyons Gary A, serving as Dir at Travere Therapeutics, Inc. (TVTX), sold 8,000 shares at $41.07 per share, for a total transaction value of $328,560.00. Following this transaction, Lyons Gary A now holds 57,500 shares of TVTX.

This sale represents a 12.00% decrease in Lyons Gary A's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, April 14, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, April 16, 2026, 2 days after the trade was made.

Travere Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.